reglab/housing_qa huggingface dataset:
UT Code § 58-17b-610.8 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 6 - Regulation of the Practice of Pharmacy Operating Standards|Section 610.8 - Prescription devices.

 Effective 5/12/2020  58-17b-610.8. Prescription devices.    (1) The following documents from a prescribing practitioner shall be considered a prescription for purposes of dispensing of and payment for a device described in Subsection (3), if the device is prescribed or indicated by the document and the document is on file with a pharmacy:   (a) a written prescription; or     (b) a written record of a patient's:   (i) current diagnosis; or     (ii) treatment protocol.         (2) A pharmacist or pharmacy intern at a pharmacy at which a document that is considered a prescription under Subsection (1) is on file may dispense a prescription device described in Subsection (3) to the patient in accordance with:   (a) the document that is considered a prescription under Subsection (1); and     (b) rules made by the division under Subsection (4).       (3) This section applies to:   (a) nebulizers;     (b) spacers for use with nebulizers or inhalers; and     (c) diabetic testing supplies.       (4) The division shall make rules in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, and in consultation with the board, the Physicians Licensing Board created in Section 58-67-201, and the Osteopathic Physician and Surgeon's Licensing Board created in Section 58-68-201, to implement this section.    Enacted by Chapter 372, 2020 General Session
UT Code § 58-17b-611 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 6 - Regulation of the Practice of Pharmacy Operating Standards|Section 611 - Pharmacy records.

58-17b-611. Pharmacy records.    (1) Each pharmacy shall maintain its prescription files and other records in accordance with this chapter, division rules made in collaboration with the board, and federal regulations.     (2) Each out-of-state mail service pharmacy shall maintain its prescription files in accordance with applicable rules or regulations of the state in which its facilities are located and federal regulations.    Enacted by Chapter 280, 2004 General Session
UT Code § 58-17b-612 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 6 - Regulation of the Practice of Pharmacy Operating Standards|Section 612 - Supervision -- Pharmacist-in-charge.

 Effective 5/14/2019  58-17b-612. Supervision -- Pharmacist-in-charge.    (1)   (a) Any pharmacy, except a wholesaler, distributor, out-of-state mail service pharmacy, or class E pharmacy, shall be under the general supervision of at least one pharmacist licensed to practice in Utah. One pharmacist licensed in Utah shall be designated as the pharmacist-in-charge, whose responsibility it is to oversee the operation of the pharmacy.     (b) Notwithstanding Subsection 58-17b-102(70), a supervising pharmacist does not have to be in the pharmacy or care facility but shall be available via a telepharmacy system for immediate contact with the supervised pharmacy technician or pharmacy intern if:   (i) the pharmacy is located in an area of need as defined by the division, in consultation with the board, by rule made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act;     (ii) the supervising pharmacist described in Subsection (1)(a) is not available;     (iii) the telepharmacy system maintains records and files quarterly reports as required by division rule to assure that patient safety is not compromised; and     (iv) the arrangement is approved by the division in collaboration with the board.       (c) Subsection (1)(b) applies to a pharmacy that is located in a hospital only if the hospital is controlled by a local board that owns no more than two hospitals; and     (d) A supervising pharmacist may not supervise more than two pharmacies simultaneously under Subsection (1)(b).       (2) Each out-of-state mail service pharmacy shall designate and identify to the division a pharmacist holding a current license in good standing issued by the state in which the pharmacy is located and who serves as the pharmacist-in-charge for all purposes under this chapter.    Amended by Chapter 343, 2019 General Session
UT Code § 58-17b-613 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 6 - Regulation of the Practice of Pharmacy Operating Standards|Section 613 - Patient counseling.

 Effective 5/12/2015  58-17b-613. Patient counseling.    (1) A pharmacy shall verbally offer to counsel a patient or a patient's agent in a personal face-to-face discussion regarding each prescription drug dispensed, if the patient or patient's agent:   (a) delivers the prescription in person to the pharmacist or pharmacy intern; or     (b) receives the drug in person at the time it is dispensed at the pharmacy facility.       (2) A pharmacist or pharmacy intern at a pharmacy that receives a prescription from a patient by means other than personal delivery, and that dispenses prescription drugs to the patient by means other than personal delivery, shall:   (a) provide patient counseling to a patient regarding each prescription drug the pharmacy dispenses; and     (b) provide each patient with a toll-free telephone number by which the patient can contact a pharmacist or pharmacy intern at the pharmacy for counseling.       (3) Notwithstanding the provisions of Subsections (1) and (2), a pharmacist or a pharmacy intern may provide patient counseling to an individual under the jurisdiction of the Utah Department of Corrections or a county detention facility via a written, telephone, or electronic communication.    Amended by Chapter 336, 2015 General Session
UT Code § 58-17b-614 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 6 - Regulation of the Practice of Pharmacy Operating Standards|Section 614 - Notification.

 Effective 5/12/2020  58-17b-614. Notification.    (1) A pharmacy shall report in writing to the division not later than 10 business days:   (a) before the date of:   (i) a permanent closure of the pharmacy facility;     (ii) a change of name or ownership of the pharmacy facility;     (iii) a change of location of the pharmacy facility;     (iv) a sale or transfer of any controlled substance as a result of the permanent closing or change of ownership of the pharmacy facility; or     (v) any matter or occurrence that the division requires by rule to be reported; or       (b) after the day on which:   (i) a final administrative disciplinary order is issued against the pharmacy license holder by the regulatory or licensing agency of the state in which the pharmacy is located if the pharmacy is a class D pharmacy;     (ii) a final order against a pharmacist is issued who is designated as the pharmacist-in-charge of the pharmacy by the regulatory or licensing agency of the state in which the pharmacy is located if the pharmacy is a class D pharmacy; or     (iii) any matter or occurrence that the division requires by rule to be reported.         (2) A pharmacy shall report in writing to the division a disaster, accident, or emergency that may affect the purity or labeling of a drug, medication, device, or other material used in the diagnosis or treatment of injury, illness, or disease immediately upon the occurrence of the disaster, accident, or emergency as defined by rule.     (3) A reporting pharmacy shall maintain a copy of any notification required by this section for two years and make a copy available for inspection.    Amended by Chapter 339, 2020 General Session
UT Code § 58-17b-616 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 6 - Regulation of the Practice of Pharmacy Operating Standards|Section 616 - Drug stock sales -- Labeling.

58-17b-616. Drug stock sales -- Labeling.    (1) A manufacturer, wholesaler, or distributor of prescription drugs may not sell or give any prescription drug to any person, unless the prescription drug stock container bears a label containing information as defined by rule, the name and place of business of the manufacturer of the finished dosage form of the drug, and if different from the manufacturer, the name and place of business of the packer or distributor.     (2) Each tablet or capsule shall be marked with an identification code or monogram, unless waived by the division.     (3) Each stock package shall bear an expiration date and lot number.    Enacted by Chapter 280, 2004 General Session
UT Code § 58-17b-617 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 6 - Regulation of the Practice of Pharmacy Operating Standards|Section 617 - Limitations on distribution of prescription drugs by pharmaceutical manufacturers or wholesalers.

58-17b-617. Limitations on distribution of prescription drugs by pharmaceutical manufacturers or wholesalers.    (1) A pharmaceutical manufacturer or pharmaceutical wholesaler may not provide a prescription drug to any person, except as defined by rule.     (2)   (a) Prescription drugs that are not controlled substances may be:   (i) distributed or provided as drug samples to a person licensed within the state to sell, prescribe, administer, or conduct research with legend drugs; and     (ii) supplied in connection with a manufacturer's patient assistance program to be distributed to qualifying patients enrolled in the program.       (b) Controlled substance prescription drugs may be sold or provided only:   (i) upon the issuance of an order or request by a person appropriately licensed under state and federal law to sell, prescribe, administer, or conduct research with prescription drugs; and     (ii) upon the establishment of documents in the possession of the manufacturer or distributor recording the purchaser, type of drug, quantity of drug, date of shipment, and date of delivery.         (3) Purchasers or those in receipt of drugs under this section shall maintain records in accordance with federal and state laws regarding controlled substances.    Enacted by Chapter 280, 2004 General Session
UT Code § 58-17b-618 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 6 - Regulation of the Practice of Pharmacy Operating Standards|Section 618 - Compliance with state and federal laws.

58-17b-618. Compliance with state and federal laws.  The entities licensed under Sections 58-17b-301 and 58-17b-302 shall comply with all state and federal laws and regulations relating to the practice of pharmacy.  Enacted by Chapter 280, 2004 General Session
UT Code § 58-17b-621 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 6 - Regulation of the Practice of Pharmacy Operating Standards|Section 621 - Automated pharmacy systems.

58-17b-621. Automated pharmacy systems.  Automated pharmacy systems can be utilized in licensed pharmacies, remote locations under the jurisdiction of the Utah State Board of Pharmacy, and licensed health care facilities where legally permissible, as approved by the division in collaboration with the board, and described in rule.  Enacted by Chapter 280, 2004 General Session
UT Code § 58-17b-623 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 6 - Regulation of the Practice of Pharmacy Operating Standards|Section 623 - Disposal of unused prescription drugs.

58-17b-623. Disposal of unused prescription drugs.    (1) A pharmacy may accept unused prescription drugs for disposal in accordance with administrative rules adopted by the division.     (2) The division shall adopt administrative rules regarding a pharmacy accepting unused prescription drugs for disposal as permitted by federal law and regulation relating to the disposal of unused prescription drugs.    Enacted by Chapter 61, 2012 General Session
UT Code § 58-17b-624 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 6 - Regulation of the Practice of Pharmacy Operating Standards|Section 624 - Prescription drugs -- Sale to a practitioner for office use.

 Effective 7/1/2014  58-17b-624. Prescription drugs -- Sale to a practitioner for office use.    (1) A pharmacy licensed under this chapter may, subject to rules established by the division, repackage or compound a prescription drug for sale to a practitioner if:   (a) the prescription drug:   (i) does not include a compounded drug; or     (ii)   (A) includes a compounded drug; and     (B) is not a controlled substance;         (b) the pharmacy labels the prescription drug "for office use only";     (c) the practitioner administers the drug to a patient in the practitioner's office or facility; and     (d) except in accordance with Title 58, Chapter 17b, Part 8, Dispensing Medical Practitioner and Dispensing Medical Practitioner Clinic Pharmacy, the practitioner does not dispense the drug to the patient.       (2) The division shall establish, in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, prescription drug labeling and control standards for a prescription drug that a pharmacy provides to a practitioner under this section.    Enacted by Chapter 385, 2014 General SessionAmended by Chapter 385, 2014 General Session, (Coordination Clause)  Coordination clause direction to modify language.
UT Code § 58-17b-625 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 6 - Regulation of the Practice of Pharmacy Operating Standards|Section 625 - Administration of a long-acting injectable and naloxone.

 Effective 5/5/2021  58-17b-625. Administration of a long-acting injectable and naloxone.    (1) A pharmacist may, in accordance with this section, administer a drug described in Subsection (2).     (2) Notwithstanding the provisions of Subsection 58-17b-102(57)(c)(ii)(B), the division shall make rules in collaboration with the board and, when appropriate, the Physicians Licensing Board created in Section 58-67-201, and in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, to establish training for a pharmacist to administer naloxone and long-acting injectables intramuscularly.     (3) A pharmacist may not administer naloxone or a long-acting injectable intramuscularly unless the pharmacist:   (a) completes the training described in Subsection (2);     (b) administers the drug at a clinic or community pharmacy, as those terms are defined by the division, by administrative rule made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act; and     (c) is directed by the physician, as that term is defined in Section 58-67-102 or Section 58-68-102, who issues the prescription to administer the drug.      Amended by Chapter 340, 2021 General Session
UT Code § 58-17b-627 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 6 - Regulation of the Practice of Pharmacy Operating Standards|Section 627 - Prescription of drugs or devices by a pharmacist.

 Effective 5/5/2021  58-17b-627. Prescription of drugs or devices by a pharmacist.    (1) Beginning January 1, 2022, a pharmacist may prescribe a prescription drug or device if:   (a) prescribing the prescription drug or device is within the scope of the pharmacist's training and experience;     (b) the prescription drug or device is designated by the division by rule under Subsection (3)(a); and     (c) the prescription drug or device is not a controlled substance that is included in Schedules I, II, III, or IV of:   (i) Section 58-37-4; or     (ii) the federal Controlled Substances Act, Title II, P.L. 91-513.         (2) Nothing in this section requires a pharmacist to issue a prescription for a prescription drug or device.     (3) The division shall make rules in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, to:   (a) designate the prescription drugs or devices that may be prescribed by a pharmacist under this section, beginning with prescription drugs or devices that address a public health concern that is designated by the Department of Health, including:   (i) post-exposure HIV prophylaxis;     (ii) pre-exposure HIV prophylaxis;     (iii) self-administered hormonal contraceptives;     (iv) smoking cessation; and     (v) naloxone;       (b) create guidelines that a pharmacist must follow when prescribing a prescription drug or device, including guidelines:   (i) for notifying the patient's primary care or other health care provider about the prescription; and     (ii) to prevent the over-prescription of drugs or devices including but not limited to antibiotics;       (c) address when a pharmacist should refer the patient to an appropriate health care provider or otherwise encourage the patient to seek further medical care; and     (d) implement the provisions of this section.       (4) The division shall make rules under Subsection (3) in collaboration with:   (a) individuals representing pharmacies and pharmacists;     (b) individuals representing physicians and advanced practice clinicians; and     (c)   (i) if the executive director of the Department of Health is a physician, the executive director of the Department of Health;     (ii) if the executive director of the Department of Health is not a physician, a deputy director who is a physician in accordance with Subsection 26-1-9(4); or     (iii) a designee of the individual described in Subsection (4)(c)(i) or (ii).         (5) Before November 1 of each year, the division, in consultation with the individuals described in Subsection (4), shall:   (a) develop recommendations for statutory changes to improve patient access to prescribed drugs in the state; and     (b) report the recommendations developed under Subsection (5)(a) to the Health and Human Services Interim Committee.      Enacted by Chapter 127, 2021 General Session
UT Code § 58-17b-801 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 8 - Dispensing Medical Practitioner and Dispensing Medical Practitioner Clinic Pharmacy|Section 801 - Title.

 Effective 7/1/2014  58-17b-801. Title.  This part is known as "Dispensing Medical Practitioner and Dispensing Medical Practitioner Clinic Pharmacy." Enacted by Chapter 72, 2014 General Session
UT Code § 58-17b-802 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 8 - Dispensing Medical Practitioner and Dispensing Medical Practitioner Clinic Pharmacy|Section 802 - Definitions.

 Effective 5/10/2016  58-17b-802. Definitions.  As used in this part:  (1)   (a) "Cosmetic drug" means a prescription drug that:   (i) is for the purpose of promoting attractiveness or altering the appearance of an individual; and     (ii)   (A) is listed as a cosmetic drug subject to the exemption under this section by the division by administrative rule; or     (B) has been expressly approved for online dispensing, whether or not it is dispensed online or through a physician's office.         (b) "Cosmetic drug" does not include a prescription drug that is:   (i) a controlled substance;     (ii) compounded by the physician; or     (iii) prescribed for or used by the patient for the purpose of diagnosing, curing, or preventing a disease.         (2) "Employer sponsored clinic" means:   (a) an entity that has a medical director who is licensed as a physician as defined in Section 58-67-102 and offers health care only to the employees of an exclusive group of employers and the employees' dependents; or     (b) a clinic designated as a clinic for state employees and their dependents by the Public Employees' Benefit and Insurance Program under the pilot program created by Section 49-20-413 including all the patients at that clinic, regardless of the patients' participation in the pilot program.       (3) "Health care" is as defined in Section 31A-1-301.     (4)   (a) "Injectable weight loss drug" means an injectable prescription drug:   (i) prescribed to promote weight loss; and     (ii) listed as an injectable prescription drug subject to exemption under this section by the division by administrative rule.       (b) "Injectable weight loss drug" does not include a prescription drug that is a controlled substance.       (5) "Prepackaged drug" means a prescription drug that:   (a) is not listed under federal or state law as a Schedule I, II, III, IV, or V drug; and     (b) is packaged in a fixed quantity per package by:   (i) the drug manufacturer;     (ii) a pharmaceutical wholesaler or distributor; or     (iii) a pharmacy licensed under this title.        Amended by Chapter 159, 2016 General Session
UT Code § 58-17b-804 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 8 - Dispensing Medical Practitioner and Dispensing Medical Practitioner Clinic Pharmacy|Section 804 - Qualifications for licensure as a dispensing medical practitioner clinic pharmacy.

 Effective 7/1/2014  58-17b-804. Qualifications for licensure as a dispensing medical practitioner clinic pharmacy.    (1) An applicant for a license as a dispensing medical practitioner clinic pharmacy shall comply with Section 58-17b-306.     (2)   (a) Notwithstanding Section 58-17b-302, a pharmacy licensed under this part is not required to have a pharmacist-in-charge if:   (i) the pharmacy has designated a dispensing medical practitioner as responsible for all activities of the pharmacy; and     (ii) the pharmacy complies with administrative rules adopted by the division in consultation with the Board of Pharmacy and the governing bodies of the practitioners described in Subsection 58-17b-102(23)(a).       (b) Notwithstanding Subsection 58-17b-306(1)(e), the division, in consultation with the Board of Pharmacy and the governing boards of the practitioners described in Subsection 58-17b-102(23)(a), may modify the operating standards for a dispensing medical practitioner clinic pharmacy.      Enacted by Chapter 72, 2014 General Session